Home › Funds › Wilmington Savings Fund Society, FSB › ABT

Wilmington Savings Fund Society, FSB position in ABT

ABBOTT LABORATORIES · Health Care

Wilmington Savings Fund Society, FSB reported holding 264,824 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$26.2M, representing 0.60% of its reported portfolio and ranking #41 among its reported holdings. Wilmington Savings Fund Society, FSB has disclosed ABT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)264.82K sh
Reported value held$26.17M
Portfolio Weight0.60%
First reportedQ3 2023
Last changeAdd
Updated2026-10-23

Last updated: 2026-10-23 · Source: SEC EDGAR Form 13F-HR

How Wilmington Savings Fund Society, FSB's ABT position evolved

Wilmington Savings Fund Society, FSB first disclosed a stake in ABT in Q3 2023 at 257,786 shares (US$25.0M). The position peaked in Q2 2025 at 297,664 shares, worth US$40.5M. Across 12 filings, Wilmington Savings Fund Society, FSB increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 264,824 shares valued at US$26.2M — an increase of 5,855 shares quarter over quarter.. Notable position changes include a 33% increase in Q3 2024 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 257.79K $24.97M New
Q1 2024 250.32K $28.45M Reduce
Q2 2024 250.52K $26.03M Hold
Q3 2024 332.19K $37.87M Add
Q4 2024 311.89K $35.28M Reduce
Q1 2025 304.21K $40.35M Reduce
Q2 2025 297.66K $40.49M Reduce
Q3 2025 272.11K $36.45M Reduce
Q4 2025 267.29K $33.49M Reduce
Q1 2026 262.70K $26.97M Reduce
Q2 2026 258.97K $23.50M Reduce
Q3 2026 264.82K $26.17M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Wilmington Savings Fund Society, FSB held ABT?

Wilmington Savings Fund Society, FSB has disclosed ABT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Wilmington Savings Fund Society, FSB's current position in ABT?

As of Q3 2026, Wilmington Savings Fund Society, FSB holds 264.82K shares of ABT (ABBOTT LABORATORIES), valued at $26.17M, representing 0.60% of its reported portfolio and ranking #41.

Has Wilmington Savings Fund Society, FSB been buying or selling ABT?

In the latest 13F filing (Q3 2026), Wilmington Savings Fund Society, FSB increased its position in ABT. The position peaked in Q2 2025 at 297.66K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.